Marinus Charts The Way Forward For Ganaxolone Amid Business Challenges

 
• By John Davis

Phase II results for Marinus’s ganaxolone in postpartum depression are a mixed bag, but the US biotech sees potential in this and other neurological indications, probably with partners.  

Magnolia
Pink magnolias in bloom • Source: Shutterstock

More from Neurological

More from Therapy Areas